GGrantIndex
← Leaderboards

David W Rowe

University Of Connecticut Sch Of Med/Dnt

$20,023,977
Attributed
$24,883,427
Total exposure
20
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$27,980,014 · 22

By mechanism

R01$14,095,573 · 6
U01$5,873,100 · 1
U54$4,636,582 · 4
R21$1,480,444 · 4
R24$968,657 · 1
P30$599,542 · 1

Top collaborators

Most similar at University Of Connecticut Sch Of Med/Dnt

Same institution · by research overlap

Others in their field

Top investigators on “Tissues

Research focus

TissuesBaseOsteoblastsCellsPathway InteractionsBoneResearch PersonnelAffectDesignSkeletalGrantMapsMolecularGenesCartilageProtocols DocumentationSkeletonCommunitiesStructureOsteogenesisGeneticProgramsSamplingAdult

Grant awards (71)

Archiving and Sharing Skeletal Phenotyping Data$446,323
R24 · FY2025 · AR
Archiving and Sharing Skeletal Phenotyping Data$522,334
R24 · FY2024 · AR
Coordination Core$534,537
U54 · FY2023 · AR · contact PI
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues$534,537
U54 · FY2023 · AR · contact PI
Skeletal Phenotyping of Heterozygotes from IMPC Embryonic Lethal Lines$519,015
R01 · FY2023 · HD · contact PI
Coordination Core$100,000
U54 · FY2023 · AR · contact PI
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues$100,000
U54 · FY2023 · AR · contact PI
Skeletal Phenotyping of Heterozygotes from IMPC Embryonic Lethal Lines$537,904
R01 · FY2022 · HD · contact PI
Coordination Core$535,000
U54 · FY2022 · AR · contact PI
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues$535,000
U54 · FY2022 · AR · contact PI
Skeletal Phenotyping of Heterozygotes from IMPC Embryonic Lethal Lines$556,517
R01 · FY2021 · HD · contact PI
Coordination Core$462,295
U54 · FY2021 · AR · contact PI
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues$462,295
U54 · FY2021 · AR · contact PI
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues$257,508
U54 · FY2021 · AR · contact PI
3D Cellular and Molecular Mapping within Skeletal Tissue$100,000
U54 · FY2021 · AR · contact PI
Skeletal Phenotyping of Heterozygotes from IMPC Embryonic Lethal Lines$584,901
R01 · FY2020 · HD · contact PI
Coordination Core$507,705
U54 · FY2020 · AR · contact PI
High resolution 3D mapping of cellular heterogeneity within multiple types of mineralized tissues$507,705
U54 · FY2020 · AR · contact PI
Skeletal Phenotyping of Heterozygotes from IMPC Embryonic Lethal Lines$606,269
R01 · FY2019 · HD · contact PI
Skeletal Phenotyping of KOMP Mice$596,924
R01 · FY2017 · AR · contact PI
Targeted Correction of Dominant Mutations of Type I Collagen Causing Severe OI$327,250
R01 · FY2017 · AR · contact PI
Skeletal Phenotyping of KOMP Mice$628,412
R01 · FY2016 · AR · contact PI
Targeted Correction of Dominant Mutations of Type I Collagen Causing Severe OI$327,250
R01 · FY2016 · AR · contact PI
Skeletal Phenotyping of KOMP Mice$645,211
R01 · FY2015 · AR · contact PI
Targeted Correction of Dominant Mutations of Type I Collagen Causing Severe OI$272,203
R01 · FY2015 · AR · contact PI
Phenotyping Skeletal QTLs in a DO Mouse Population$178,361
R21 · FY2015 · AR · contact PI
Skeletal Phenotyping of KOMP Mice$657,397
R01 · FY2014 · AR · contact PI
Targeted Correction of Dominant Mutations of Type I Collagen Causing Severe OI$393,448
R01 · FY2014 · AR · contact PI
Phenotyping Skeletal QTLs in a DO Mouse Population$235,560
R21 · FY2014 · AR · contact PI
Skeletal Phenotyping of KOMP Mice$701,384
R01 · FY2013 · AR · contact PI
Targeted Correction of Dominant Mutations of Type I Collagen Causing Severe OI$327,250
R01 · FY2013 · AR · contact PI
Targeted Correction of Dominant Mutations of Type I Collagen Causing Severe OI$43,079
R01 · FY2013 · AR · contact PI
4-D Imaging Cell/Scaffold Interplays During In Vivo Bone Repair Process$202,298
R21 · FY2012 · AR
Adult Stem Cells: Osteoblast Differentiation and Engraftment$296,369
R01 · FY2011 · AR · contact PI
4-D Imaging Cell/Scaffold Interplays During In Vivo Bone Repair Process$179,815
R21 · FY2011 · AR
Assessing lineage decisions of musculoskeletal progenitor cells with aging$368,083
R01 · FY2010 · AR · contact PI
Adult Stem Cells: Osteoblast Differentiation and Engraftment$308,718
R01 · FY2010 · AR · contact PI
Assessing lineage decisions of musculoskeletal progenitor cells with aging$371,801
R01 · FY2009 · AR · contact PI
Adult Stem Cells: Osteoblast Differentiation and Engraftment$311,836
R01 · FY2009 · AR · contact PI
Promotor GFP Markers of the Osteoprogenitor Lineage$302,553
R01 · FY2009 · AR · contact PI
GFP Reporters for the chondrocyte lineage$162,800
R21 · FY2009 · AR · contact PI
Assessing lineage decisions of musculoskeletal progenitor cells with aging$371,801
R01 · FY2008 · AR · contact PI
Adult Stem Cells: Osteoblast Differentiation and Engraftment$311,836
R01 · FY2008 · AR · contact PI
Promotor GFP Markers of the Osteoprogenitor Lineage$302,553
R01 · FY2008 · AR · contact PI
GFP Reporters for the chondrocyte lineage$195,360
R21 · FY2008 · AR · contact PI
Assessing lineage decisions of musculoskeletal progenitor cells with aging$111,000
R01 · FY2008 · AR · contact PI
Assessing lineage decisions of musculoskeletal progenitor cells with aging$379,391
R01 · FY2007 · AR · contact PI
Adult Stem Cells: Osteoblast Differentiation and Engraftment$318,200
R01 · FY2007 · AR · contact PI
Promotor GFP Markers of the Osteoprogenitor Lineage$308,728
R01 · FY2007 · AR · contact PI
Assessing lineage decisions of musculoskeletal progenitor cells with aging$390,719
R01 · FY2006 · AR · contact PI
Promotor GFP Markers of the Osteoprogenitor Lineage$317,948
R01 · FY2006 · AR · contact PI
Promotor GFP Markers of the Osteoprogenitor Lineage$325,050
R01 · FY2005 · AR
The Osteoprogenitor Lineage$1,845,195
U01 · FY2004 · DK
The Osteoprogenitor Lineage$285,000
U01 · FY2004 · DK
Development of a GFP sensitive apoptosis marker gene$108,750
R21 · FY2004 · AR
Expression profiling the Osteoprogenitor Lineage$10,000
R13 · FY2004 · DK
The Osteoprogenitor Lineage$1,848,890
U01 · FY2003 · DK
PROMOTER GFP MARKERS OF THE OSTEOPROGENITOR LINEAGE$316,463
R01 · FY2003 · AR
Development of a GFP sensitive apoptosis marker gene$108,750
R21 · FY2003 · AR
The Osteoprogenitor Lineage$1,894,015
U01 · FY2002 · DK
PROMOTER GFP MARKERS OF THE OSTEOPROGENITOR LINEAGE$316,463
R01 · FY2002 · AR
Development of a GFP sensitive apoptosis marker gene$108,750
R21 · FY2002 · AR
ENGRAFTMENT OF OSTEOPROGENITOR CELL IN BONE$0
P01 · FY2002 · AR
Core Center for Musculoskeletal Research$527,542
P30 · FY2001 · AR
PROMOTER GFP MARKERS OF THE OSTEOPROGENITOR LINEAGE$314,463
R01 · FY2001 · AR
Core Center for Musculoskeletal Research$72,000
P30 · FY2001 · AR
ENGRAFTMENT OF OSTEOPROGENITOR CELL IN BONE$0
P01 · FY2001 · AR
PROMOTER GFP MARKERS OF THE OSTEOPROGENITOR LINEAGE$327,184
R01 · FY2000 · AR
STRATEGIES OF SYSTEMIC GENE THERAPY OF BONE$156,510
P01 · FY2000 · AR
AN INTEGRATED SYSTEM FOR A DNA SEQUENCING CORE FACILITY$156,355
S10 · FY2000 · RR
BEHAVIORAL GENETIC ANALYSIS OF ADOLESCENT HEALTH RISK$3,251
P01 · FY2000 · HD